Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.
2.

Drug metabolism by flavin-containing monooxygenases of human and mouse.

Phillips IR, Shephard EA.

Expert Opin Drug Metab Toxicol. 2017 Feb;13(2):167-181. doi: 10.1080/17425255.2017.1239718. Epub 2016 Sep 29. Review.

PMID:
27678284
3.

Some distinctions between flavin-containing and cytochrome P450 monooxygenases.

Cashman JR.

Biochem Biophys Res Commun. 2005 Dec 9;338(1):599-604. Epub 2005 Aug 11. Review.

PMID:
16112078
4.
5.

Flavin-containing monooxygenases: mutations, disease and drug response.

Phillips IR, Shephard EA.

Trends Pharmacol Sci. 2008 Jun;29(6):294-301. doi: 10.1016/j.tips.2008.03.004. Epub 2008 Apr 16. Review.

PMID:
18423897
6.

Human flavin-containing monooxygenase: substrate specificity and role in drug metabolism.

Cashman JR.

Curr Drug Metab. 2000 Sep;1(2):181-91. Review.

PMID:
11465082
7.

Genetic polymorphisms of flavin-containing monooxygenase (FMO).

Krueger SK, Williams DE, Yueh MF, Martin SR, Hines RN, Raucy JL, Dolphin CT, Shephard EA, Phillips IR.

Drug Metab Rev. 2002 Aug;34(3):523-32. Review.

PMID:
12214664
8.

The mammalian flavin-containing monooxygenases: molecular characterization and regulation of expression.

Hines RN, Cashman JR, Philpot RM, Williams DE, Ziegler DM.

Toxicol Appl Pharmacol. 1994 Mar;125(1):1-6. Review.

PMID:
8128486
9.

An overview of the mechanism, substrate specificities, and structure of FMOs.

Ziegler DM.

Drug Metab Rev. 2002 Aug;34(3):503-11. Review.

PMID:
12214662
10.

Mutation, polymorphism and perspectives for the future of human flavin-containing monooxygenase 3.

Zhou J, Shephard EA.

Mutat Res. 2006 Jun;612(3):165-71. Epub 2006 Feb 14. Review.

PMID:
16481213
11.

Role of flavin-containing monooxygenase in drug development.

Cashman JR.

Expert Opin Drug Metab Toxicol. 2008 Dec;4(12):1507-21. doi: 10.1517/17425250802522188 . Review.

PMID:
19040327
12.
13.
14.

Human flavin-containing monooxygenases.

Cashman JR, Zhang J.

Annu Rev Pharmacol Toxicol. 2006;46:65-100. Review.

PMID:
16402899
15.

Flavin-containing monooxygenase genetic polymorphism: impact on chemical metabolism and drug development.

Koukouritaki SB, Hines RN.

Pharmacogenomics. 2005 Dec;6(8):807-22. Review.

PMID:
16296944
16.
17.

Role of hepatic flavin-containing monooxygenase 3 in drug and chemical metabolism in adult humans.

Cashman JR, Park SB, Berkman CE, Cashman LE.

Chem Biol Interact. 1995 Apr 28;96(1):33-46. Review.

PMID:
7720103
18.

Developmental and tissue-specific expression of human flavin-containing monooxygenases 1 and 3.

Hines RN.

Expert Opin Drug Metab Toxicol. 2006 Feb;2(1):41-9. Review.

PMID:
16863467
19.

The potential of knockout mouse lines in defining the role of flavin-containing monooxygenases in drug metabolism.

Shephard EA, Phillips IR.

Expert Opin Drug Metab Toxicol. 2010 Sep;6(9):1083-94. doi: 10.1517/17425255.2010.503705. Review.

PMID:
20629583
20.

Flavin-containing monooxygenases in aging and disease: Emerging roles for ancient enzymes.

Rossner R, Kaeberlein M, Leiser SF.

J Biol Chem. 2017 Jul 7;292(27):11138-11146. doi: 10.1074/jbc.R117.779678. Epub 2017 May 17. Review.

PMID:
28515321

Supplemental Content

Support Center